The ROE as of November 2024 (TTM) for Disc Medicine, Inc. (IRON) is -25.24%

According to Disc Medicine, Inc.’s latest financial reports and current stock price. The company's current ROE is -25.24%. This represents a change of 290.12% compared to the average of -6.47% of the last 4 quarters.

Disc Medicine, Inc. (IRON) Historical ROE (quarterly & annually)

How has IRON ROE performed in the past?

The mean historical ROE of Disc Medicine, Inc. over the last ten years is -6.26%. The current -25.24% ROE has changed 303.49% with respect to the historical average. Over the past ten years (40 quarters), IRON's ROE was at its highest in in the December 2020 quarter at 183.81%. The ROE was at its lowest in in the December 2021 quarter at -14.28%.

Disc Medicine, Inc. (IRON) ROE by Quarter and Year

Discovering the peaks and valleys of Disc Medicine, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Disc Medicine, Inc. (IRON) Average ROE

How has IRON ROE performed in the past?

The current ROE of Disc Medicine, Inc. (IRON) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Disc Medicine, Inc. (IRON) ROE vs. Peers

How is IRON’s ROE compared to its peers?

Disc Medicine, Inc.’s ROE is greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than AnaptysBio, Inc. (-287.94%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Olema Pharmaceuticals, Inc. (-53.55%), greater than Larimar Therapeutics, Inc. (-35.87%), less than Fennec Pharmaceuticals Inc. (31.99%), greater than Orchestra BioMed Holdings, Inc. (-107.04%), greater than Biomea Fusion, Inc. (-118.90%), greater than Structure Therapeutics Inc. (-16.40%), less than DICE Therapeutics, Inc. (56.07%), greater than Morphic Holding, Inc. (-26.62%), greater than Terns Pharmaceuticals, Inc. (-32.76%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than Amylyx Pharmaceuticals, Inc. (-85.39%), greater than MoonLake Immunotherapeutics (-15.89%), greater than Crinetics Pharmaceuticals, Inc. (-36.12%), greater than Centessa Pharmaceuticals plc (-52.22%), less than Entrada Therapeutics, Inc. (16.11%),

Build a custom stock screener for Disc Medicine, Inc. (IRON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Disc Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Disc Medicine, Inc. (IRON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Disc Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.